Eurobio Scientific Gross Profit vs. Cash And Equivalents

ALERS Stock   25.75  0.05  0.19%   
Based on the measurements of profitability obtained from Eurobio Scientific's financial statements, Eurobio Scientific SA may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Eurobio Scientific's ability to earn profits and add value for shareholders.
For Eurobio Scientific profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Eurobio Scientific to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Eurobio Scientific SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Eurobio Scientific's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Eurobio Scientific SA over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Eurobio Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eurobio Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eurobio Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Eurobio Scientific Cash And Equivalents vs. Gross Profit Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Eurobio Scientific's current stock value. Our valuation model uses many indicators to compare Eurobio Scientific value to that of its competitors to determine the firm's financial worth.
Eurobio Scientific SA is number one stock in gross profit category among its peers. It also is number one stock in cash and equivalents category among its peers creating about  1.03  of Cash And Equivalents per Gross Profit. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eurobio Scientific's earnings, one of the primary drivers of an investment's value.

Eurobio Cash And Equivalents vs. Gross Profit

Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Eurobio Scientific

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
99.41 M
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Eurobio Scientific

Cash

 = 

Bank Deposits

+

Liquidities

 = 
102.39 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Eurobio Cash And Equivalents Comparison

Eurobio Scientific is currently under evaluation in cash and equivalents category among its peers.

Eurobio Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Eurobio Scientific. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Eurobio Scientific position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Eurobio Scientific's important profitability drivers and their relationship over time.

Use Eurobio Scientific in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eurobio Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eurobio Scientific will appreciate offsetting losses from the drop in the long position's value.

Eurobio Scientific Pair Trading

Eurobio Scientific SA Pair Trading Analysis

The ability to find closely correlated positions to Eurobio Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eurobio Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eurobio Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eurobio Scientific SA to buy it.
The correlation of Eurobio Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eurobio Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eurobio Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eurobio Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Eurobio Scientific position

In addition to having Eurobio Scientific in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Retail Thematic Idea Now

Retail
Retail Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Retail theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Retail Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Eurobio Stock Analysis

When running Eurobio Scientific's price analysis, check to measure Eurobio Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurobio Scientific is operating at the current time. Most of Eurobio Scientific's value examination focuses on studying past and present price action to predict the probability of Eurobio Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurobio Scientific's price. Additionally, you may evaluate how the addition of Eurobio Scientific to your portfolios can decrease your overall portfolio volatility.